These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

73 related articles for article (PubMed ID: 3054491)

  • 1. [Molecular mechanisms of proteolytic processing of viral proteins and the problem of antiviral chemotherapy and vaccine design].
    Zhirnov OP
    Mol Biol (Mosk); 1988; 22(3):581-600. PubMed ID: 3054491
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Proteolytic processing of viral and bacterial proteins and its potentials in controlled modification for vaccine design].
    Zhirnov OP
    Mol Gen Mikrobiol Virusol; 1986 Aug; (8):3-8. PubMed ID: 3537769
    [No Abstract]   [Full Text] [Related]  

  • 3. Characterization of proteinase cleavage sites in the N-terminal region of the RNA1-encoded polyprotein from Arabis mosaic virus (subgroup A nepovirus).
    Wetzel T; Chisholm J; Bassler A; Sanfaçon H
    Virology; 2008 May; 375(1):159-69. PubMed ID: 18308360
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Picornaviral processing: some new ideas.
    Palmenberg AC
    J Cell Biochem; 1987 Mar; 33(3):191-8. PubMed ID: 3553216
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of different forms of herpes simplex replication-defective mutant viruses as vaccines in a mouse model of HSV-2 genital infection.
    Da Costa XJ; Morrison LA; Knipe DM
    Virology; 2001 Sep; 288(2):256-63. PubMed ID: 11601897
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Processing of the hepatitis C virus precursor protein.
    Shimotohno K; Tanji Y; Hirowatari Y; Komoda Y; Kato N; Hijikata M
    J Hepatol; 1995; 22(1 Suppl):87-92. PubMed ID: 7602084
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Human coronavirus 229E papain-like proteases have overlapping specificities but distinct functions in viral replication.
    Ziebuhr J; Schelle B; Karl N; Minskaia E; Bayer S; Siddell SG; Gorbalenya AE; Thiel V
    J Virol; 2007 Apr; 81(8):3922-32. PubMed ID: 17251282
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cleavage sites of the "P3 region" in the nonstructural polyprotein precursor of a dicistrovirus.
    Nakashima N; Nakamura Y
    Arch Virol; 2008; 153(10):1955-60. PubMed ID: 18810573
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Internal ribosomal entry site scanning of the poliovirus polyprotein: implications for proteolytic processing.
    Paul AV; Mugavero J; Molla A; Wimmer E
    Virology; 1998 Oct; 250(1):241-53. PubMed ID: 9770438
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Viral proteases: an emerging therapeutic target.
    Korant BD
    Crit Rev Biotechnol; 1988; 8(2):149-57. PubMed ID: 3067861
    [TBL] [Abstract][Full Text] [Related]  

  • 11. "HIV-peplotion vaccine"--a novel approach to protection against AIDS by transepithelial transport of viral peptides to Langerhans cells for long-term antiviral CTL response. (A review).
    Becker Y
    Acta Microbiol Immunol Hung; 1996; 43(1):1-17. PubMed ID: 8806938
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Plant-derived vaccine protects target animals against a viral disease.
    Dalsgaard K; Uttenthal A; Jones TD; Xu F; Merryweather A; Hamilton WD; Langeveld JP; Boshuizen RS; Kamstrup S; Lomonossoff GP; Porta C; Vela C; Casal JI; Meloen RH; Rodgers PB
    Nat Biotechnol; 1997 Mar; 15(3):248-52. PubMed ID: 9062924
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antigenic differences among Newcastle disease virus strains of different genotypes used in vaccine formulation affect viral shedding after a virulent challenge.
    Miller PJ; King DJ; Afonso CL; Suarez DL
    Vaccine; 2007 Oct; 25(41):7238-46. PubMed ID: 17719150
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Gene technology in the diagnosis of viruses and vaccine development].
    Löwer J
    Arzneimittelforschung; 1988 Mar; 38(3A):438-41. PubMed ID: 3134900
    [TBL] [Abstract][Full Text] [Related]  

  • 15. An in-frame insertion into the Sindbis virus 6K gene leads to defective proteolytic processing of the virus glycoproteins, a trans-dominant negative inhibition of normal virus formation, and interference in virus shut off of host-cell protein synthesis.
    Schlesinger MJ; London SD; Ryan C
    Virology; 1993 Mar; 193(1):424-32. PubMed ID: 8094927
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Development of replication-defective adenovirus serotype 5 containing the capsid and 3C protease coding regions of foot-and-mouth disease virus as a vaccine candidate.
    Mayr GA; Chinsangaram J; Grubman MJ
    Virology; 1999 Oct; 263(2):496-506. PubMed ID: 10544121
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Proteolytic processing in infectious bursal disease virus: identification of the polyprotein cleavage sites by site-directed mutagenesis.
    Sánchez AB; Rodriguez JF
    Virology; 1999 Sep; 262(1):190-9. PubMed ID: 10489352
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Protective immune responses induced by the immunization of mice with a recombinant bacteriophage displaying an epitope of the human respiratory syncytial virus.
    Bastien N; Trudel M; Simard C
    Virology; 1997 Jul; 234(1):118-22. PubMed ID: 9234952
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification of proteolytic cleavage sites by quantitative proteomics.
    Enoksson M; Li J; Ivancic MM; Timmer JC; Wildfang E; Eroshkin A; Salvesen GS; Tao WA
    J Proteome Res; 2007 Jul; 6(7):2850-8. PubMed ID: 17547438
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mutagenesis of the yellow fever virus NS2A/2B cleavage site: effects on proteolytic processing, viral replication, and evidence for alternative processing of the NS2A protein.
    Nestorowicz A; Chambers TJ; Rice CM
    Virology; 1994 Feb; 199(1):114-23. PubMed ID: 8116234
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.